Latest Healthcare & Nursing CEU News
- ANA Supports Nursing Home Healthcare Orders
- Nursing Shortages Dangerous – New Research
- Flu Vaccines Banned in Japan
- California Blue Shield Hikes Health Insurance Rates
- EPA lowers Fluoride in Water due to Health Hazards
- California Gov. Jerry Brown moves Energy & Jobs
- Obama Signs 9/11 WTC Health & Compensation Act
- Obama to Sign Food Safety Act
24 March 2010
The FDA notes that there is no evidence of a safety concern from the contaminated Rotarix vaccine. The suspension of its use is viewed as a preventative measure. The FDA will conduct research into the viral contamination issue to determine whether the PCV1 contaminant is an intact virus or merely DNA fragments. Additional recommendations concerning the vaccine will be made in about one to two months when the FDA is convening an expert panel to look into this issue. The FDA will report this information to patients, doctors, nurses, and the World Health Organization (WHO) as information surfaces.
The Director of the Centers for Disease Control and Prevention speculates that many countries will continue to use the Rotarix vaccine until further information becomes available. Citing dangers of rotavirus, the director anticipates that the vaccine warning will be weighed against the threat of the disease. In balance, he feels that many countries will risk the potential dangers of the vaccine to prevent rotavirus outbreaks. RotaTeq vaccine, manufactured by Merk pharmaceuticals, is not affected by this FDA warning. RotaTeq is also used to prevent rotavirus and no viral contamination has been discovered in this product.
| < Prev | Next > |
|---|
